ADSS

GAOTU TECHEDU SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Gaotu Techedu Inc. f/k/a GSX Techedu Inc. - GOTU, G

Retrieved on: 
Wednesday, January 11, 2023

NEW ORLEANS, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 28, 2023 to file lead plaintiff applications in a securities class action lawsuit against Gaotu Techedu Inc. f/k/a GSX Techedu Inc. (NYSE: GOTU, GSX), if they purchased the Company’s American depository shares (“ADSs”) between March 5, 2021 and July 23, 2021, inclusive (the “Class Period”).

Key Points: 
  • NEW ORLEANS, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 28, 2023 to file lead plaintiff applications in a securities class action lawsuit against Gaotu Techedu Inc. f/k/a GSX Techedu Inc. (NYSE: GOTU, GSX), if they purchased the Company’s American depository shares (“ADSs”) between March 5, 2021 and July 23, 2021, inclusive (the “Class Period”).
  • This action is pending in the United States District Court for the Eastern District of New York.
  • If you purchased ADSs of Gaotu and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-gotu/ to learn more.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by February 28, 2023.

H World Group Limited Announces Pricing of Public Offering of American Depositary Shares

Retrieved on: 
Tuesday, January 10, 2023

SHANGHAI, China, Jan. 10, 2023 (GLOBE NEWSWIRE) -- H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World” or the “Company”), a key player in the global hotel industry, today announced that the pricing of its underwritten public offering (the “Offering”) of 6,190,000 American depositary shares (“ADSs”), each representing ten ordinary shares of the Company, at a price of US$42.0 per ADS.

Key Points: 
  • SHANGHAI, China, Jan. 10, 2023 (GLOBE NEWSWIRE) -- H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World” or the “Company”), a key player in the global hotel industry, today announced that the pricing of its underwritten public offering (the “Offering”) of 6,190,000 American depositary shares (“ADSs”), each representing ten ordinary shares of the Company, at a price of US$42.0 per ADS.
  • In addition, the underwriters for this Offering have a 30-day option to purchase up to an aggregate of 928,500 additional ADSs from the Company.
  • and UBS Securities LLC are acting as joint underwriters for the Offering.
  • H World undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by applicable law.

H World Group Limited Announces Proposed Public Offering of American Depositary Shares

Retrieved on: 
Tuesday, January 10, 2023

SHANGHAI, China, Jan. 10, 2023 (GLOBE NEWSWIRE) -- H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World” or the “Company”), a key player in the global hotel industry, today announced that it has commenced an underwritten public offering (the “Offering”) of US$260 million of American depositary shares of the Company (“ADSs”) in the United States, each representing ten ordinary shares of the Company.

Key Points: 
  • SHANGHAI, China, Jan. 10, 2023 (GLOBE NEWSWIRE) -- H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World” or the “Company”), a key player in the global hotel industry, today announced that it has commenced an underwritten public offering (the “Offering”) of US$260 million of American depositary shares of the Company (“ADSs”) in the United States, each representing ten ordinary shares of the Company.
  • The underwriters are expected to have a 30-day option to purchase up to US$39 million of additional ADSs from the Company.
  • The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed.
  • H World undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by applicable law.

Gaotu Techedu Inc. (GOTU, GSX) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against Gaotu Techedu Inc.

Retrieved on: 
Monday, January 9, 2023

The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Gaotu Techedu Inc. (NYSE: GOTU) American depository shares ("ADSs") between March 5, 2021 and July 23, 2021, for violations of the Securities Exchange Act of 1934.

Key Points: 
  • The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Gaotu Techedu Inc. (NYSE: GOTU) American depository shares ("ADSs") between March 5, 2021 and July 23, 2021, for violations of the Securities Exchange Act of 1934.
  • Gaotu purports to be a technology-driven education company, providing online K-12 after-school tutoring services in the People's Republic of China.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Gaotu.
  • Shareholders who want to act as lead plaintiff for the class must file their papers by February 28, 2023.

Bilibili Inc. Prices Notes Repurchases and Equity Offering

Retrieved on: 
Monday, January 9, 2023

The Company entered into an equity underwriting and notes exchange agreement with Goldman Sachs (Asia) L.L.C.

Key Points: 
  • The Company entered into an equity underwriting and notes exchange agreement with Goldman Sachs (Asia) L.L.C.
  • Concurrently with the ADS Offering, Goldman Sachs and its applicable affiliate(s), as duly engaged and authorized by the Company, entered into separate and individually negotiated agreements with certain holders of the Exchange Notes to purchase the Exchange Notes from such holders for cash (the “Notes Purchase”).
  • The closing of each Notes Exchange and Notes Purchase is contingent upon, among other things, the closing of the ADS Offering.
  • This press release contains information about the pending ADS Offering, Notes Exchange and Notes Purchase, and there can be no assurance that any of the ADS Offering, Notes Exchange or Notes Purchase will be completed.

Bilibili Inc. Announces Proposed Notes Repurchases and Equity Offering

Retrieved on: 
Monday, January 9, 2023

(“Goldman Sachs”) and its applicable affiliate(s) from certain holders of the Exchange Notes through private negotiations.

Key Points: 
  • (“Goldman Sachs”) and its applicable affiliate(s) from certain holders of the Exchange Notes through private negotiations.
  • Such Notes Purchase will be funded by the net proceeds from the ADS Offering.
  • The closing of each of the Notes Exchange and Notes Purchase is contingent upon, among other things, the closing of the ADS Offering.
  • This press release contains information about the pending ADS Offering, Notes Exchange and Notes Purchase, and there can be no assurance that any of the ADS Offering, Notes Exchange or Notes Purchase will be completed.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of BioLineRx Ltd. (BLRX) on Behalf of Investors

Retrieved on: 
Monday, January 9, 2023

Law Offices of Howard G. Smith announces an investigation on behalf of BioLineRx Ltd. (“BioLine” or the “Company”) (NASDAQ: BLRX ) investors concerning the Company’s possible violations of federal securities laws.

Key Points: 
  • Law Offices of Howard G. Smith announces an investigation on behalf of BioLineRx Ltd. (“BioLine” or the “Company”) (NASDAQ: BLRX ) investors concerning the Company’s possible violations of federal securities laws.
  • On September 15, 2022, BioLine announced that Kreos Capital VII Aggregator SCSP will provide the Company with term loans in an aggregate principal amount of up to $40 million.
  • On this news, the Company’s share price fell 33% to close at $1.02 per share on September 19, 2022.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Steakholder Foods Ltd. Announces Closing of $6.5 Million Public Offering

Retrieved on: 
Tuesday, January 10, 2023

The warrants issued have a five-year term, are exercisable immediately and have an exercise price of $1.00 per ADS.

Key Points: 
  • The warrants issued have a five-year term, are exercisable immediately and have an exercise price of $1.00 per ADS.
  • In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 975,000 ADSs and/or warrants at the public offering price, less discounts and commissions, solely to cover over-allotments, if any.
  • The Company intends to use the net proceeds from this offering for general corporate purposes.
  • The offering was made only by means of a prospectus forming part of the effective registration statement.

NuCana Announces Receipt of NASDAQ Notice

Retrieved on: 
Friday, January 6, 2023

EDINBURGH, United Kingdom, Jan. 06, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that it received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) dated January 3, 2023, indicating that, based upon a closing bid price of less than $1.00 per share for the Company’s American Depositary Shares (“ADSs”) for the prior 30 consecutive business day period, the Company no longer satisfies Nasdaq Listing Rule 5450(a)(1).

Key Points: 
  • The Notification Letter has no immediate effect on the listing of the ADSs, and they will continue to trade on The Nasdaq Global Select Market under the symbol “NCNA”.
  • Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the applicable grace period to regain compliance is 180 days, or until July 3, 2023.
  • During this time, the Company's ADSs will continue to be listed and trade on The Nasdaq Global Select Market.
  • The Company's business and operations are not affected by the receipt of the Notification Letter.

ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX

Retrieved on: 
Wednesday, January 4, 2023

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=8781 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.